What is the International Normalized Ratio (INR) for a patient with a Prothrombin Time (PT) of 18.5 seconds, given a Mean Normal Prothrombin Time (MNPT) of 11.5 seconds and an International Sensitivity Index (ISI) of 1.21?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating the International Normalized Ratio (INR)

The correct INR calculation for a patient with PT of 18.5 seconds, mean normal PT of 11.5 seconds, and ISI of 1.21 is 1.6 (option B).

Calculation Method

The INR is calculated using the following formula as defined by the World Health Organization (WHO) guidelines 1:

INR = (PT patient / PT normal)^ISI

Where:

  • PT patient = Patient's prothrombin time (18.5 seconds)
  • PT normal = Mean normal prothrombin time (MNPT) (11.5 seconds)
  • ISI = International Sensitivity Index (1.21)

Substituting the values: INR = (18.5 / 11.5)^1.21 INR = (1.608)^1.21 INR = 1.6

Understanding the INR Calculation Components

Mean Normal Prothrombin Time (MNPT)

  • The MNPT is defined as the geometric mean of prothrombin times from the healthy adult population 1
  • For practical purposes, it can be calculated from at least 20 fresh samples from healthy individuals of both sexes 1
  • In this case, the MNPT is provided as 11.5 seconds

International Sensitivity Index (ISI)

  • The ISI is a measure of the sensitivity of a thromboplastin reagent relative to an international standard 1
  • It's used to standardize PT results across different laboratories and reagents 1
  • The ISI value of 1.21 indicates the relative sensitivity of the thromboplastin reagent being used

Clinical Significance

  • The normal INR range is 0.8-1.2 for individuals not on anticoagulation therapy 2
  • An INR of 1.6 indicates mild coagulation abnormality but is below the therapeutic range (2.0-3.0) typically targeted for patients on vitamin K antagonists 2
  • This value may represent:
    • Early/inadequate anticoagulation if the patient is on warfarin
    • Mild coagulopathy from other causes (liver disease, vitamin K deficiency)
    • Need for dose adjustment if therapeutic anticoagulation is the goal

Common Pitfalls in INR Calculation

  1. Using arithmetic mean instead of geometric mean for MNPT calculation - This can lead to inaccurate INR values 1

  2. Incorrect application of the ISI exponent - The ISI must be applied as an exponent to the PT ratio, not multiplied 1

  3. Using inappropriate ISI values - Each thromboplastin reagent/instrument combination should have a specific ISI value 1, 3

  4. Not accounting for special populations - The standard INR calculation may not be appropriate for patients with lupus anticoagulant or liver disease 1, 2

The INR calculation is a critical component of monitoring anticoagulation therapy, particularly for patients on vitamin K antagonists, and accurate calculation is essential for proper dosing and patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Coagulation Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Standardization of Prothrombin Time/International Normalized Ratio (PT/INR).

International journal of laboratory hematology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.